Assessment of Post-Vaccination Tick-Borne Encephalitis IgG

The purpose of this study is to evaluate the patient's immune system response to the Tick-Borne Encephalitis virus after vaccination. The study focuses on measuring the level of IgG antibodies, as these antibodies are formed in the body in response to infection or vaccination. This is an important step to determine whether the vaccination has triggered an appropriate immune response that could protect against Tick-Borne Encephalitis.

During the study, the concentration of IgG antibodies in the patient's blood sample will be evaluated to determine if they are sufficiently high to provide protection against the Tick-Borne Encephalitis virus. This study may be important to ensure that the vaccination has triggered an appropriate immune response, which is crucial for the patient's health and protection from the disease.